• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey.

作者信息

Palandri Francesca, Piciocchi Alfonso, De Stefano Valerio, Breccia Massimo, Finazzi Guido, Iurlo Alessandra, Fazi Paola, Soddu Stefano, Martino Bruno, Siragusa Sergio, Albano Francesco, Passamonti Francesco, Vignetti Marco, Vannucchi Alessandro M

机构信息

Institute of Hematology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

GIMEMA Data Center, Fondazione GIMEMA Franco Mandelli Onlus, Rome, Italy.

出版信息

Leukemia. 2020 Oct;34(10):2805-2808. doi: 10.1038/s41375-020-0953-3. Epub 2020 Jul 3.

DOI:10.1038/s41375-020-0953-3
PMID:32620840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7333222/
Abstract
摘要

相似文献

1
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey.意大利冠状病毒大流行如何影响费城阴性慢性骨髓增殖性肿瘤的临床管理——一项GIMEMA MPN WP调查
Leukemia. 2020 Oct;34(10):2805-2808. doi: 10.1038/s41375-020-0953-3. Epub 2020 Jul 3.
2
Critical importance of early introduction of prevention measures for SARS-CoV-2 infection in endoscopy units.在内镜检查科室尽早引入严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染预防措施的至关重要性。
Gastrointest Endosc. 2020 Oct;92(4):936-937. doi: 10.1016/j.gie.2020.06.023. Epub 2020 Jun 15.
3
An evaluation of the SARS-CoV-2 epidemic 16 days after the end of social confinement in Hungary.匈牙利结束社会隔离措施16天后对新型冠状病毒肺炎疫情的评估。
Geroscience. 2020 Oct;42(5):1221-1223. doi: 10.1007/s11357-020-00237-6. Epub 2020 Jul 31.
4
A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).《关于〈2019年冠状病毒病、中东呼吸综合征和严重急性呼吸综合征的比较概述：综述文章〉的评论》（《国际外科学杂志》2020年；81卷：第1 - 8页）
Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.
5
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and Transfusion Medicine: reflections from Italy.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行与输血医学：来自意大利的思考
Blood Transfus. 2020 Mar;18(2):77-78. doi: 10.2450/2020.0071-20.
6
Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy.新冠疫情对意大利北部地区结核病治疗结局的影响。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.02665-2020. Print 2020 Oct.
7
Recurrence of COVID-19 after recovery: a case report from Italy.新冠康复后复发：来自意大利的一例病例报告。
Infection. 2020 Dec;48(6):965-967. doi: 10.1007/s15010-020-01444-1. Epub 2020 May 16.
8
Comment on 'Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: A nationwide Italian survey' by Alice Indini et al.对爱丽丝·因迪尼等人所著的《新型冠状病毒肺炎疫情期间意大利肿瘤内科部门的重组：一项全国性调查》的评论
Eur J Cancer. 2020 Jul;134:3-5. doi: 10.1016/j.ejca.2020.04.047. Epub 2020 May 16.
9
The use of simulation-CT's as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic.在严重急性呼吸综合征冠状病毒2大流行期间，使用模拟CT作为2019冠状病毒病的筛查工具。
Radiother Oncol. 2020 Oct;151:17-19. doi: 10.1016/j.radonc.2020.07.006. Epub 2020 Jul 15.
10
Opening Up Resident Education During the Coronavirus Disease (COVID-19) Pandemic and Beyond.在冠状病毒病（COVID-19）大流行期间及之后开放住院医师教育。
AJR Am J Roentgenol. 2020 Oct;215(4):W48. doi: 10.2214/AJR.20.23427. Epub 2020 Jul 17.

引用本文的文献

1
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives.骨髓纤维化的流行病学及疾病特征：意大利与全球视角的比较分析
Front Oncol. 2024 Jul 24;14:1382872. doi: 10.3389/fonc.2024.1382872. eCollection 2024.
2
Telemedicine and its acceptance by patients with type 2 diabetes mellitus at a single care center during the COVID-19 emergency: A cross-sectional observational study.在 COVID-19 紧急情况下，单一护理中心的 2 型糖尿病患者对远程医疗及其接受度的横断面观察研究。
PLoS One. 2023 Feb 15;18(2):e0269350. doi: 10.1371/journal.pone.0269350. eCollection 2023.
3
JAK inhibitors and COVID-19.JAK 抑制剂与 COVID-19。
J Immunother Cancer. 2022 Apr;10(4). doi: 10.1136/jitc-2021-002838.
4
How the COVID-19 Pandemic Reshaped the Management of Leukemia and Affected Patient Outcomes.COVID-19 大流行如何重塑白血病的治疗管理并影响患者结局。
Curr Treat Options Oncol. 2022 May;23(5):688-702. doi: 10.1007/s11864-022-00975-z. Epub 2022 Mar 25.
5
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios.新冠疫情期间的费城染色体阴性慢性骨髓增殖性肿瘤：挑战与未来展望
Cancers (Basel). 2021 Sep 23;13(19):4750. doi: 10.3390/cancers13194750.
6
Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka.资源有限环境下的 COVID-19 疫情中的血液癌症照护；来自斯里兰卡的单中心经验。
PLoS One. 2021 Sep 17;16(9):e0256941. doi: 10.1371/journal.pone.0256941. eCollection 2021.
7
Being a Myeloproliferative Patient in COVID-19 Era: The Mytico Study.新冠疫情时代的骨髓增殖性疾病患者：Mytico研究
Front Oncol. 2021 Apr 15;11:668261. doi: 10.3389/fonc.2021.668261. eCollection 2021.
8
Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.由于 COVID-19 大流行导致的癌症医疗保健延误和中断：系统评价。
JCO Glob Oncol. 2021 Feb;7:311-323. doi: 10.1200/GO.20.00639.
9
COVID-19: High-JAKing of the Inflammatory "Flight" by Ruxolitinib to Avoid the Cytokine Storm.新冠病毒肺炎：芦可替尼对炎症“逃逸”的高度抑制以避免细胞因子风暴
Front Oncol. 2021 Jan 8;10:599502. doi: 10.3389/fonc.2020.599502. eCollection 2020.
10
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.COVID-19 伴骨髓增殖性肿瘤患者突然停用鲁索替尼后死亡率高。
Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.